Method Validation by Phase of Development: An Acceptable Analytical Practice

This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.

Related Content:

Regulatory/GMP ComplianceAnalyticsProcess ValidationManufacturingQuality SystemsAnalytical Method DevelopmentPharmaceutical Technology-11-02-2004

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

Using Image Analysis to Differentiate Particle Size and Shape in Drug Products with Multiple Components